Systemic Sclerosis
📧 Sign up to get email alerts when something new happens for Systemic Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Clinical Study of Divozilimab in Patients With Systemic Scleroderma [Phase 3]
Biocad's Phase 3 clinical study of Divozilimab for systemic sclerosis is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Self-management Telehealth Program for Scleroderma [NA]
A completed clinical trial evaluating a self-management telehealth program for systemic sclerosis (scleroderma).
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2) [Phase 2]
This Phase 2 trial evaluated intravenous iloprost in subjects with Raynaud's phenomenon secondary to systemic sclerosis; results have been p…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: IgG-4 Levels in Systemic Sclerosis
Completed clinical trial investigating IgG-4 levels in systemic sclerosis. The snippet provides status but does not include trial results.
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients [Phase 2]
Phase 2 trial evaluating the safety and tolerability of oral Ixazomib in scleroderma-related lung disease was terminated, with results poste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot
A pilot study evaluating early diagnosis of systemic sclerosis in a general rheumatology clinic has been completed.
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Apollo Device for Fatigue in Systemic Sclerosis [NA]
A completed clinical trial evaluated the Apollo Device for fatigue in systemic sclerosis. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases [Phase 2]
Phase 2 clinical trial update on BCMA-CD19 CAR-T therapy for refractory autoimmune diseases, currently recruiting. The study targets several…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Klotho and Mineral Bone Density in Systemic Sclerosis
Completed clinical trial evaluating the relationship between Klotho and mineral bone density in systemic sclerosis.
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Effectiveness of Cannabinoids on Appetite in Scleroderma [Phase 3]
A Phase 3 clinical trial evaluated cannabinoids for improving appetite in individuals with systemic sclerosis and related malnutrition, and …
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Making it Work Program for Systemic Sclerosis [NA]
Clinical trial update indicates the study focused on systemic sclerosis (scleroderma) and has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma [Phase 3]
Phase 3 trial evaluating the efficacy and safety of oral bosentan for healing and prevention of digital ulcers in patients with systemic scl…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis [Phase 2]
Phase 2 trial evaluating selexipag for Raynaud's phenomenon in adults with systemic sclerosis. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma [Phase 2, Phase 3]
Phase 2/3 trials evaluated the efficacy and safety of oral bosentan for pulmonary fibrosis associated with systemic sclerosis, and the studi…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Open-label Study With Bosentan in Interstitial Lung Disease [Phase 2, Phase 3]
Open-label Phase 2/3 study of bosentan in interstitial lung disease and systemic sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Bosentan in Systemic Sclerosis [Phase 4]
Phase 4 clinical trial evaluating bosentan for systemic sclerosis with digital ulcers has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases [Phase 4]
Phase 4 clinical trial is currently enrolling by invitation to evaluate herpes zoster vaccination in patients with inflammatory rheumatic di…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Scleroderma Treatment With Autologous Transplant (STAT) Study [Phase 2]
Phase 2 trial results update for autologous hematopoietic stem cell transplantation in systemic sclerosis (STAT) study; results have been po…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Use of Selective JAK Inhibitor in ILD and Skin Tightness of Systemic Sclerosis Versus MMF [Phase 3]
Phase 3 clinical trial evaluating a selective JAK inhibitor for interstitial lung disease due to systemic disease and skin tightness in syst…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases [Phase 1]
Amgen reported completion of a Phase 1 study of MEDI7734 in Type I interferon-mediated autoimmune diseases, including dermatomyositis, polym…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Impact of Transcutaneous Auricular Vagus Nerve Stimulation on Digestive Symptoms in Systemic Sclerosis Systemic Sclerosis [NA]
Clinical trial update indicates completion of a study evaluating transcutaneous auricular vagus nerve stimulation for digestive symptoms in …
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Exercise in People With Systemic Sclerosis [NA]
This is an update on a completed clinical trial evaluating an exercise program for people with systemic sclerosis.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: A Study of Guselkumab in Participants With Systemic Sclerosis [Phase 2]
This Phase 2 clinical trial evaluating guselkumab in systemic sclerosis has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
This clinical trial update notes that the study evaluating gynecological follow-up in patients with autoimmune diseases and inflammatory rhe…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease [NA]
This clinical trial update reports a study of YTS109 cell injection for recurrent or refractory autoimmune diseases that is currently recrui…